Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

767 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I dose-escalation, safety/tolerability, and preliminary efficacy study of the intratumoral administration of GEN0101 in patients with advanced melanoma.
Kiyohara E, Tanemura A, Sakura K, Nakajima T, Myoui A, Yamazaki N, Kiyohara Y, Katayama I, Fujimoto M, Kaneda Y. Kiyohara E, et al. Among authors: yamazaki n. Cancer Immunol Immunother. 2022 Aug;71(8):2041-2049. doi: 10.1007/s00262-021-03122-z. Epub 2022 Jan 5. Cancer Immunol Immunother. 2022. PMID: 34984539 Free PMC article. Clinical Trial.
Identification of melanoma antigens using a Serological Proteome Approach (SERPA).
Suzuki A, Iizuka A, Komiyama M, Takikawa M, Kume A, Tai S, Ohshita C, Kurusu A, Nakamura Y, Yamamoto A, Yamazaki N, Yoshikawa S, Kiyohara Y, Akiyama Y. Suzuki A, et al. Among authors: yamazaki n. Cancer Genomics Proteomics. 2010 Jan-Feb;7(1):17-23. Cancer Genomics Proteomics. 2010. PMID: 20181627
Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients.
Iizuka A, Komiyama M, Tai S, Oshita C, Kurusu A, Kume A, Ozawa K, Nakamura Y, Ashizawa T, Yamamoto A, Yamazaki N, Yoshikawa S, Kiyohara Y, Yamaguchi K, Akiyama Y. Iizuka A, et al. Among authors: yamazaki n. Immunol Lett. 2011 Mar 30;135(1-2):64-73. doi: 10.1016/j.imlet.2010.09.013. Epub 2010 Oct 12. Immunol Lett. 2011. PMID: 20932861
Prediction of additional lymph node positivity and clinical outcome of micrometastases in sentinel lymph nodes in cutaneous melanoma: a multi-institutional study of 450 patients in Japan.
Namikawa K, Yamazaki N, Nakai Y, Ihn H, Tomita Y, Uhara H, Takenouchi T, Kiyohara Y, Moroi Y, Yamamoto Y, Otsuka F, Kamiya H, Iizuka H, Hatta N, Kadono T. Namikawa K, et al. Among authors: yamazaki n. J Dermatol. 2012 Feb;39(2):130-7. doi: 10.1111/j.1346-8138.2011.01318.x. Epub 2011 Sep 28. J Dermatol. 2012. PMID: 21950448
Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial.
Oshita C, Takikawa M, Kume A, Miyata H, Ashizawa T, Iizuka A, Kiyohara Y, Yoshikawa S, Tanosaki R, Yamazaki N, Yamamoto A, Takesako K, Yamaguchi K, Akiyama Y. Oshita C, et al. Among authors: yamazaki n. Oncol Rep. 2012 Oct;28(4):1131-8. doi: 10.3892/or.2012.1956. Epub 2012 Aug 7. Oncol Rep. 2012. PMID: 22895835 Free PMC article. Clinical Trial.
767 results